Aurinia Reports Third Quarter and Nine Months 2021 Financial Results and Company Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Aurinia Reports Third Quarter and Nine Months 2021 Financial Results and Company Updates

Aurinia Pharmaceuticals (AUPH) Misses Q3 EPS by 6c

November 3, 2021 6:05 AM EDT

Aurinia Pharmaceuticals (NASDAQ: AUPH) reported Q3 EPS of ($0.39), $0.06 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $14.7 million versus the consensus estimate of $13.88 million.

GUIDANCE:

Aurinia Pharmaceuticals sees FY2021 revenue of $40-50 million, versus the consensus of... More